Liu, X., Tu, Y., Wang, Y., Zhou, D., Chong, Y., Shi, L., . . . Yu, R. (2020). RETRACTED ARTICLE: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway. Cancer Cell Int.
Chicago Style aipamenaLiu, Xuejiao, et al. "RETRACTED ARTICLE: Reversible Inhibitor of CRM1 Sensitizes Glioblastoma Cells to Radiation By Blocking the NF-κB Signaling Pathway." Cancer Cell Int 2020.
MLA aipamenaLiu, Xuejiao, et al. "RETRACTED ARTICLE: Reversible Inhibitor of CRM1 Sensitizes Glioblastoma Cells to Radiation By Blocking the NF-κB Signaling Pathway." Cancer Cell Int 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.